Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
Ryuta Uraki(Tokyo University of Science), Yoshihiro Kawaoka(University of Wisconsin–Madison), Tadashi Maemura(University of Wisconsin–Madison), Hiroshi Ueki(Tokyo University of Science), Shun Iida(National Institute of Infectious Diseases), Shuetsu Fukushi(National Institute of Infectious Diseases), Tadaki Suzuki(National Institute of Infectious Diseases), Seiya Yamayoshi(National Center for Global Health and Medicine), Kiyoko Iwatsuki‐Horimoto(Tokyo University of Science), Deanna Larson(Utah State University), Ahmed Kandeil(St. Jude Children's Research Hospital), Makoto Kuroda(National Institute of Infectious Diseases), Masaki Imai(Kobe University), Andrew Pekosz(Johns Hopkins University), Maki Kiso(Tokyo University of Science), Peter Halfmann(University of Wisconsin–Madison), Yuri Furusawa(Tokyo University of Science), Ken Maeda(Yamaguchi University), Yuko Sakai‐Tagawa(Tokyo University of Science), Rong Li(Utah State University), Yanan Liu(Ningbo University), Zhongde Wang(The Fourth People's Hospital of Zibo City), Shinji Watanabe(University of Miyazaki), Richard J. Webby(St. Jude Children's Research Hospital), Mutsumi Ito(Tokyo University of Science), Sohtaro Mine(National Institute of Infectious Diseases)
Cited by 110
Related Papers
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
|Nature|2012|1.5k
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus
|Nature|2007|939
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Influenza: lessons from past pandemics, warnings from current incidents
|Nature Reviews Microbiology|2005|699